Search results
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
Why BioNTech Stock Was Sinking Today
Motley Fool· 10 months agoWhat happened A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech (NASDAQ: BNTX) stock on Monday. As of...
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 11% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 10 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
Investor's Business Daily· 2 months agoBioNTech stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker...
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
Investor's Business Daily· 7 months agoCovid vaccine maker BioNTech reported a surprise profit and better-than-expected September-quarter...
BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion
Investor's Business Daily· 1 year agoBioNTech said Monday it expects roughly $5.4 billion in sales of its Covid vaccine this year, widely...
BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance
Investor's Business Daily· 2 years agoBioNTech doubled Wall Street's third-quarter profit expectations Monday and raised its full-year...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 month agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance
Investor's Business Daily· 2 years agoGerman Covid vaccine developer BioNTech lagged second-quarter estimates and reiterated disappointing...